Adalimumab induced exacerbation of psoriasis in patients with combined pemphigus: A case report
Limin Yao,Xiaoli Cai,Xiaoqing Du,Yuxin Ma
DOI: https://doi.org/10.1097/md.0000000000036988
IF: 1.6
2024-02-03
Medicine
Abstract:Psoriasis is a chronic skin disease characterized by the appearance of red, scaly plaques. [ 1 ] The disease usually affects the skin, nails and joints and may cause itching and discomfort. [ 2 ] Although the exact cause of psoriasis is unknown, it is thought to be linked to genetics, immune system abnormalities, and environmental factors. [ 3 ] Pemphigus, on the other hand, is a group of autoimmune disorders that includes several types, such as pemphigus-like epidermolysis bullosa. [ 4 ] The common feature of these diseases is the development of blisters, herpes, and ulcers on the skin and mucous membranes as a result of the immune system attacking normal intercellular adhesion proteins or adhesion structures. In this article, we report a rare case of adalimumab induced exacerbation of psoriasis patients with pemphigus.
medicine, general & internal